The UAB Cystic Fibrosis Research and Translation Core Center Administrative Core is responsible for the overall administration and coordination of the Biomedical Research Cores, Pilot & Feasibility Program, and Enrichment Program. Directed by Drs. Rowe (P01 Director) and Bedwell (Associate Director) with assistance from the experienced Research Management and Administrative Team?including Ms. Jamie Elliot, Center Business Officer and Dr. Emily Falk- Libby, Program Director-Scientific Affairs?the Core will continue to successfully support CF Center goals in the upcoming funding cycle by: 1) Establishing the overall scientific direction of the UAB P30 CF Center (e.g., directing communications between the Administrative Core, P01 investigators, members of the Center's active Internal Advisory Board, and/or external consultants on its External Advisory Board to review Center activities and identify research directions and opportunities), 2) Facilitating the objectives of all P30 components (e.g., optimizing Core resources for optimal utilization, coordinating training and professional development activities, maintaining a Center website, overseeing membership, building the Biomedical Core research base and monitoring its productivity), and 3) Integrating P30 components with other UAB NIH Centers (e.g., promoting and sharing its innovative resources and communicating with other Center leadership such as the Center for Clinical and Translational Science (UAB's CTSA site), NIDDK-Diabetes Research and Training Center, and NIDDK-Nutrition Obesity Research Center) to identify continued opportunities for multidisciplinary collaboration. In addition, specifically in support of the Center's Enrichment and Pilot & Feasibility Programs, the Administrative Core will continue to identify and integrate resources offered through the Institution to maximize trainee success and transition to independence for junior faculty as well as to apply its established, robust mechanisms for solicitation, review, and oversight of P30 pilot applications to foster new and important contributions to CF science. Overall, it is the goal of the Administrative Core to optimally promote synergy and progress within the CF P30 Center.
Solomon, George M; Bronsveld, Inez; Hayes, Kathryn et al. (2018) Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD). J Vis Exp : |
Reeves, Emer P; O'Dwyer, Ciara A; Dunlea, Danielle M et al. (2018) Ataluren, a New Therapeutic for Alpha-1 Antitrypsin-Deficient Individuals with Nonsense Mutations. Am J Respir Crit Care Med 198:1099-1102 |
McCormick, Lydia L; Phillips, Scott E; Kaza, Niroop et al. (2018) Maternal Smoking Induces Acquired CFTR Dysfunction in Neonatal Rats. Am J Respir Crit Care Med 198:672-674 |
Duncan, Gregg A; Kim, Namho; Colon-Cortes, Yanerys et al. (2018) An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy. Mol Ther Methods Clin Dev 9:296-304 |
Gelfond, Daniel; Heltshe, Sonya L; Skalland, Michelle et al. (2018) Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening. J Pediatr Gastroenterol Nutr 66:657-663 |
Birket, Susan E; Davis, Joy M; Fernandez, Courtney M et al. (2018) Development of an airway mucus defect in the cystic fibrosis rat. JCI Insight 3: |
Shei, Ren-Jay; Peabody, Jacelyn E; Kaza, Niroop et al. (2018) The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis. Curr Opin Pharmacol 43:152-165 |
Gebert, Magdalena; Bartoszewska, Sylwia; Janaszak-Jasiecka, Anna et al. (2018) PIWI proteins contribute to apoptosis during the UPR in human airway epithelial cells. Sci Rep 8:16431 |
Montoro, Daniel T; Haber, Adam L; Biton, Moshe et al. (2018) A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560:319-324 |
Lutful Kabir, Farruk; Ambalavanan, Namasivayam; Liu, Gang et al. (2018) MicroRNA-145 Antagonism Reverses TGF-? Inhibition of F508del CFTR Correction in Airway Epithelia. Am J Respir Crit Care Med 197:632-643 |
Showing the most recent 10 out of 175 publications